000			02200 a2200625 4500
005			20250517101838.0
264		0	_c20170228
008			201702s 0 0 eng d
022			_a1842-1121
024	7		_a10.15403/jgld.2014.1121.252.th3 _2doi
040			_aNLM _beng _cNLM
100	1		_aBerden, Floor A C
245	0	0	_aHigh Risk of Infection During Triple Therapy with First-Generation Protease Inhibitors: A Nationwide Cohort Study. _h[electronic resource]
260			_bJournal of gastrointestinal and liver diseases : JGLD _cJun 2016
300			_a197-204 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnti-Infective Agents _xadministration & dosage
650	0	4	_aAntiviral Agents _xadverse effects
650	0	4	_aChi-Square Distribution
650	0	4	_aComorbidity
650	0	4	_aDiabetes Mellitus _xepidemiology
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHepacivirus _xdrug effects
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHospitalization
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNetherlands _xepidemiology
650	0	4	_aNeutropenia _xchemically induced
650	0	4	_aOdds Ratio
650	0	4	_aOpportunistic Infections _xchemically induced
650	0	4	_aProtease Inhibitors _xadverse effects
650	0	4	_aPulmonary Disease, Chronic Obstructive _xepidemiology
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aSeverity of Illness Index
650	0	4	_aSex Factors
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_avan Zwietering, Inke M J M
700	1		_aMaan, Raoel
700	1		_ade Knegt, Robert J
700	1		_aKievit, Wietske
700	1		_aDrenth, Joost P H
773	0		_tJournal of gastrointestinal and liver diseases : JGLD _gvol. 25 _gno. 2 _gp. 197-204
856	4	0	_uhttps://doi.org/10.15403/jgld.2014.1121.252.th3 _zAvailable from publisher's website
999			_c26130147 _d26130147